pancracine

structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Breiterová, Kateřina: 2 articles (06/2021 - 01/2020)
2.	Cahlíková, Lucie: 2 articles (06/2021 - 01/2020)
3.	Havelek, Radim: 2 articles (06/2021 - 01/2020)
4.	Koutová, Darja: 2 articles (06/2021 - 01/2020)
5.	Řezáčová, Martina: 2 articles (06/2021 - 01/2020)
6.	Berthoux, Lionel: 1 article (01/2022)
7.	Calabrò, Viola: 1 article (01/2022)
8.	Desgagné-Penix, Isabel: 1 article (01/2022)
9.	Di Lecce, Roberta: 1 article (01/2022)
10.	Evidente, Antonio: 1 article (01/2022)

1.	Neoplasms (Cancer) 06/29/2021 - "In previous studies, pancracine exhibited cytotoxic activity against diverse human cancer cell lines in vitro. " 01/01/2022 - "Lycorine and haemanthidine showed cytotoxic activity on Hacat cells and A431 and AGS cancer cells while, pancracine exhibited selective cytotoxicity against A431 cells. " 01/22/2020 - "The growth of all studied cancer cell lines was inhibited by pancracine (montanine-type alkaloid), with IC50 values which were in the range of 2.20 to 5.15 µM."
2.	Adenocarcinoma of Lung 06/29/2021 - "Pancracine, a Montanine-Type Amaryllidaceae Alkaloid, Inhibits Proliferation of A549 Lung Adenocarcinoma Cells and Induces Apoptotic Cell Death in MOLT-4 Leukemic Cells."